Hot Consumer Service Companies To Own In Right Now

Cisco� (NASDAQ: CSCO  ) will pay $107 million in cash and retention bonuses for network and data center energy management specialist JouleX, the company announced today.

The privately held IT company will complement Cisco's own energy management systems to allow businesses to focus�on network and IT energy efficiency through software-based methods of�measuring, monitoring, and managing usage, the company said.

Noting that network-enabled devices are increasing exponentially, leading customers to seek out�energy management capabilities in the network that reduce costs,�Cisco Senior VP for Industry Solutions�Faiyaz Shahpurwala said: "JouleX's cloud-enabled, agent-less architecture will allow our partners and customers to quickly deploy this solution at scale in addressing their IT energy management needs."

Hot Consumer Service Companies To Own In Right Now: Nex Metals Exploration Ltd (NME.AX)

Nex Metals Explorations Ltd engages in the exploration and mining of mineral properties in Western Australia. The company primarily explores for gold, copper, and nickel deposits. It principally holds a 100% interest in the Kookynie gold project that consists of 44 tenements covering approximately 70 square kilometers of land located to the south of Leonora; and a 70% interest in the Yundamindera gold project that comprises 9 granted mining leases covering an area of 46.2 square kilometers located to the southeast of Leonora. The company was incorporated in 2007 and is based in East Perth, Australia.

Hot Consumer Service Companies To Own In Right Now: Idera Pharmaceuticals Inc.(IDRA)

Idera Pharmaceuticals, Inc., a biotechnology company, discovers and develops DNA- and RNA-based drug candidates for the treatment of infectious diseases, autoimmune and inflammatory diseases, cancer, and asthma and allergies, and for use as vaccine adjuvants. The company designs and creates proprietary Toll-Like Receptors (TLR) to modulate immune responses, including TLR agonist, a compound that stimulates an immune response through the targeted TLR; and TLR antagonist, a compound that blocks activation of an immune response through the targeted TLR. Its drug candidates include IMO-2125, a TLR9 agonist, which is in Phase 1 clinical trial for hepatitis C virus infection; and TLR7, 8, and 9 agonists that are in research stage for viral diseases. The company also develops IMO-3100, a dual TLR7/TLR9 antagonist, which is in preclinical development stage for autoimmune and inflammatory diseases, such as lupus, rheumatoid arthritis, multiple sclerosis, psoriasis, and colitis. In addition, its drug candidates also comprise TLR7 and TLR8 agonists that are in research stage for solid tumor cancers. The company has a licensing and collaboration agreement with Merck KGaA to research, develop, and commercialize TLR9 agonists for the treatment of cancer, excluding cancer vaccines; a license and research collaboration agreement with Merck & Co., Inc. to research, develop, and commercialize therapeutic and prophylactic vaccine products containing its TLR7, 8, and 9 agonists in the fields of cancer, infectious diseases, and Alzheimer?s disease; and a research collaboration and option agreement, and a license, development, and commercialization agreement with Novartis International Pharmaceutical, Ltd. to discover, develop, and commercialize TLR9 agonists for the treatment of asthma and allergies. The company was founded in 1989 and is based in Cambridge, Massachusetts.

Hot Biotech Companies To Invest In Right Now: Meritus Minerals Ltd (MER.V)

Meritus Minerals Limited engages in the acquisition, exploration, and development of mineral resource properties in Australia and Mongolia. It primarily focuses on the exploration of gold, copper, zinc, and base-metals. The company�s principal property includes the Gutain Davaa gold project consisting of 2 exploration licenses covering 3,928 hectares located in Mongolia. Meritus Minerals Limited was incorporated in 2005 and is headquartered in Vancouver, Canada.